Paper8537652
Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
Rice LB and 3 others. J Infect Dis, 1996. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy. Papers, record 8537652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8537652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
- PubMed
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ceftazidime | Major topic |
| Cephalosporin Resistance | Major topic |
| Cephalosporins | Major topic |
| Drug Therapy, Combination | Major topic |
| Klebsiella pneumoniae | Major topic |
| Penicillin Resistance | Major topic |
| beta-Lactamase Inhibitors | Major topic |
| Abdominal Abscess | |
| Amino Acid Sequence | |
| Ampicillin | |
| Animals | |
| Base Sequence | |
| DNA, Bacterial | |
| Escherichia coli | |
| Klebsiella Infections | |
| Molecular Biology | |
| Molecular Sequence Data | |
| Penicillanic Acid | |
| Piperacillin | |
| Piperacillin, Tazobactam Drug Combination | |
| R Factors | |
| Rats | |
| Sulbactam | |
| beta-Lactamases |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30410748 | Spread of the florfenicol resistance floR gene among clinical Klebsiella pneumoniae isolates in China. | Antimicrob Resist Infect Control | 2018 | https://conductscience.org/library/papers/30410748 | PubMed |
| 16641440 | Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16641440 | PubMed |
| 15561828 | Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15561828 | PubMed |
| 12558458 | Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. | Drugs | 2003 | https://conductscience.org/library/papers/12558458 | PubMed |
| 11959586 | Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11959586 | PubMed |
| 11095885 | Impact of Antibiotic Resistance on the Treatment of Gram-negative Sepsis. | Curr Infect Dis Rep | 2000 | https://conductscience.org/library/papers/11095885 | PubMed |
| 11095807 | The Red Menace: Emerging Issues in Antimicrobial Resistance in Gram-Negative Bacilli. | Curr Infect Dis Rep | 1999 | https://conductscience.org/library/papers/11095807 | PubMed |
| 10639363 | High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10639363 | PubMed |
| 9660996 | Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9660996 | PubMed |
| 9145868 | Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9145868 | PubMed |
| 9145849 | Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9145849 | PubMed |
| 8913451 | A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8913451 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8537652
GET https://conductscience.org/api/papers/v1/8537652/authors